Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice

被引:101
作者
Aldrovandi, GM
Zack, JA
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL ONCOL,LOS ANGELES,CA 90095
[2] UNIV CALIF LOS ANGELES,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90095
关键词
D O I
10.1128/JVI.70.3.1505-1511.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The functional roles of the human immunodeficiency virus type 1 (HIV-1) accessory genes (nef, vpr, vpu, and vif) are as yet unclear. Using the SCID-hu model system, we have examined the infectivity, replicative capacity, and pathogenicity of strains of the molecular clone HIV-1(NL4-3) that contain deletion mutations in these individual accessory genes. We determined that deletion of these genes had differential effects on both infectivity and pathogenicity. Deletion of vpr had little or no effect on viral infectivity, replication, and pathogenicity; however, deletion of vpu or vif had a significant effect on infectivity and moderate effects on pathogenicity. nef-minus strains were the most attenuated in this system, demonstrating significantly lower levels of infectivity and pathogenicity. However, deletion of these individual genes attenuated but did not abrogate the pathogenic properties of HIV-1. Mutant viruses still retained the ability to induce thymocyte depletion to various degrees if implants were infected with higher doses of virus or observed for longer periods of time. The relative contributions of these genes to in vivo pathogenic potential should be taken into consideration when one is contemplating a live attenuated vaccine for HIV-1.
引用
收藏
页码:1505 / 1511
页数:7
相关论文
共 53 条
[1]   NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS [J].
AIKEN, C ;
TRONO, D .
JOURNAL OF VIROLOGY, 1995, 69 (08) :5048-5056
[2]   THE SCID-HU MOUSE AS A MODEL FOR HIV-1 INFECTION [J].
ALDROVANDI, GM ;
FEUER, G ;
GAO, LY ;
JAMIESON, B ;
KRISTEVA, M ;
CHEN, ISY ;
ZACK, JA .
NATURE, 1993, 363 (6431) :732-736
[3]   PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J].
BABA, TW ;
JEONG, YS ;
PENNINCK, D ;
BRONSON, R ;
GREENE, MF ;
RUPRECHT, RM .
SCIENCE, 1995, 267 (5205) :1820-1825
[4]   HIV INDUCES THYMUS DEPLETION INVIVO [J].
BONYHADI, ML ;
RABIN, L ;
SALIMI, S ;
BROWN, DA ;
KOSEK, J ;
MCCUNE, JM ;
KANESHIMA, H .
NATURE, 1993, 363 (6431) :728-732
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[6]  
CANN AJ, 1988, ONCOGENE, V3, P123
[7]   OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE [J].
CHOWERS, MY ;
SPINA, CA ;
KWOH, TJ ;
FITCH, NJS ;
RICHMAN, DD ;
GUATELLI, JC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2906-2914
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN [J].
COHEN, EA ;
DEHNI, G ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3097-3099
[9]   PERIPHERAL-BLOOD MONONUCLEAR-CELLS PRODUCE NORMAL AMOUNTS OF DEFECTIVE VIF(-) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES WHICH ARE RESTRICTED FOR THE PRERETROTRANSCRIPTION STEPS [J].
COURCOUL, M ;
PATIENCE, C ;
REY, F ;
BLANC, D ;
HARMACHE, A ;
SIRE, J ;
VIGNE, R ;
SPIRE, B .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2068-2074
[10]   PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE [J].
DANIEL, MD ;
KIRCHHOFF, F ;
CZAJAK, SC ;
SEHGAL, PK ;
DESROSIERS, RC .
SCIENCE, 1992, 258 (5090) :1938-1941